Subbiah Rajasekaran

Subbiah Rajasekaran

Auto-generated profile, based on publicly available information

Subbiah Rajasekaran

Division of Biochemistry ICMR‐National Institute for Research in Environmental Health (NIREH) Bhopal Madhya Pradesh India

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2006 in Clinical and Experimental Pharmacology and Physiology
Verified
Journal Article
Closed access
PDF file
SRSubbiah Rajasekaran
Subbiah Rajasekaran
KRKasiappan Ravi
Kasiappan Ravi
KSKaruran Sivagnanam
Karuran Sivagnanam
SSSorimuthu Subramanian
Sorimuthu Subramanian

1 September 2005 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
KRKasiappan Ravi
Kasiappan Ravi
SRSubbaih Rajasekaran
Subbaih Rajasekaran
SSSorimuthu Subramanian
Sorimuthu Subramanian

4 February 2016 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
SRSubbiah Rajasekaran
Subbiah Rajasekaran
DPDhamotharan Pattarayan
Dhamotharan Pattarayan
PRP. Rajaguru
P. Rajaguru
PGP. S. Sudhakar Gandhi
P. S. Sudhakar Gandhi
RTRajesh K. Thimmulappa
Rajesh K. Thimmulappa

1 April 2004 in Journal of Medicinal Food
Verified
Journal Article
Closed access
SRS. Rajasekaran
S. Rajasekaran
KSK. Sivagnanam
K. Sivagnanam
KRK. Ravi
K. Ravi
SSS. Subramanian
S. Subramanian
In the present study an attempt has been made to evaluate the presence of hypoglycemic activity in the alcoholic extract of Aloe vera gel. Effects of oral administration of A. vera extract at a concentration of 200 and 300 mg/kg of body weight on (a) normal fasted rats, (b) oral glucose-loaded rats, and (c) streptozotocin-induced diabetic rats have been studied. A. vera extract maintain the glucose homeostasis by controlling the carbohydrate metabolizing enzymes.

5 November 2015 in Frontiers in Pharmacology
Verified
Journal Article
Open access
SRSubbiah Rajasekaran
Subbiah Rajasekaran
PRP. Rajaguru
P. Rajaguru
PGP. S. Sudhakar Gandhi
P. S. Sudhakar Gandhi
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and devastating disorder. It is characterized by alveolar epithelial cell injury and activation, infiltration of inflammatory cells, initiation of epithelial mesenchymal transition (EMT), aberrant proliferation and activation of fibroblasts, exaggerated deposition of extracellular matrix (ECM) proteins, and finally leading to the destruction of lung parenchyma. MicroRNAs (miRNAs) are endogenous small non-coding RNA molecules that post-transcriptionally regulate gene expression in diverse biological and pathological processes, including cell proliferation, differentiation, apoptosis and metastasis. As a result, miRNAs have emerged as a major area of biomedical research with relevance to pulmonary fibrosis. In this context, the present review discusses specific patterns of dysregulated miRNAs in patients with IPF. Further, we discuss the current understanding of miRNAs involvement in regulating lung inflammation, TGF-β1-mediated EMT and fibroblast differentiation processes, ECM genes expression, and in the progression of lung fibrosis. The possible future directions that might lead to novel therapeutic strategies for the treatment of pulmonary fibrosis are also reviewed.

2 January 2021 in Critical Reviews in Toxicology
Verified
Journal Article
Closed access
RSRajasekaran Subbiah
Rajasekaran Subbiah
RTRajnarayan R. Tiwari
Rajnarayan R. Tiwari
The herbicide paraquat (PQ; 1,1’-dimethyl-4,4’-bipyridylium dichloride) is a highly toxic organic heterocyclic herbicide that has been widely used in agricultural settings. Since its commercial introduction in the early 1960s, numerous cases of fatal PQ poisonings attributed to accidental and/or intentional ingestion of PQ concentrated formulations have been reported. The clinical manifestations of the respiratory system during the acute phase of PQ poisoning mainly include acute lung injury (ALI)/acute respiratory distress syndrome (ARDS), followed by pulmonary fibrosis in a later phase. The focus of this review is to summarize the most recent publications related to PQ-induced lung toxicity as well as the underlying molecular mechanisms for PQ-mediated pathologic processes. Growing sets of data from in vitro and in vivo models have demonstrated the involvement of the PQ in regulating lung oxidative stress, inflammatory response, epigenetics, apoptosis, autophagy, and the progression of lung fibrosis. The article also summarizes novel therapeutic avenues based on a literature review, which can be explored as potential means to combat PQ-induced lung toxicity. Finally, we also presented clinical studies on the association of PQ exposure with the incidence of lung injury and pulmonary fibrosis.